(Q34570634)

3 August 2017

1 reference

title

Serum amyloid A and high-density lipoprotein cholesterol: serum markers of inflammation in sarcoidosis and other systemic disorders (English)

1 reference

3 August 2017

0 references

1 reference

Salazar A

1

1 reference

3 August 2017

Pintó X

series ordinal

2

1 reference

3 August 2017

Mañá J

series ordinal

3

1 reference

3 August 2017

publication date

1 December 2001

1 reference

European Journal of Clinical Investigation

3 August 2017

published in

1 reference

3 August 2017

volume

31

1 reference

3 August 2017

issue

12

1 reference

3 August 2017

page(s)

1070-1077

1 reference

Changes in serum lipoprotein pattern induced by acute infections

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00913.X

Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00913.X

Lipoprotein alterations in patients with HIV infection: relation with cellular and humoral immune markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00913.X

Altered high density lipoprotein metabolism in patients with myeloproliferative disorders and hypocholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00913.X

Soluble interleukin 2 receptors in patients with sarcoidosis. Possible origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00913.X

Serum amyloid A: An acute phase apolipoprotein and precursor of AA amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00913.X

Influence of serum amyloid A on cholesterol esterification in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00913.X

Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00913.X

Comparison of the binding and endocytosis of high-density lipoprotein from healthy (HDL) and inflamed (HDL(SAA)) donors by murine macrophages of four different mouse strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00913.X

High-density lipoprotein cholesterol is reduced in patients with sarcoidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00913.X

Serum amyloid A (SAA): an acute phase protein and apolipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00913.X

Regulation of serum amyloid A protein expression during the acute-phase response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00913.X

Cytokine-induced differential expression of serum amyloid A genes in fetal and neonatal rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00913.X

Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00913.X

Increased plasma concentrations of serum amyloid A: an indicator of the acute-phase response after cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00913.X

Biochemical changes in sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00913.X

Are the pulmonary function tests and the markers of activity helpful to establish the prognosis of sarcoidosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00913.X

Association between angiotensin II receptor gene polymorphism and serum angiotensin converting enzyme (SACE) activity in patients with sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00913.X

Effect of short-term, low-dose corticosteroids on plasma lipoprotein lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00913.X

Dyslipoproteinaemia in patients with active, chronic polyarthritis. a study on serum lipoproteins and triglyceride clearance (intravenous fat tolerance test)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00913.X

Hypocholesterolaemia and abnormal high-density lipoprotein in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00913.X

Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. II. Effects of anti-inflammatory and disease-modifying drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00913.X

Plasma lipids and lipoproteins in juvenile chronic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00913.X

10.1046/J.1365-2362.2001.00913.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference